These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4622788)

  • 1. Profile of insulin release due to intrapancreatic glyburide infusion.
    Colwell AR; Zuckerman L
    Diabetes; 1972 Apr; 21(4):209-15. PubMed ID: 4622788
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide.
    Artini D; Abbiati R; Orsini G; Parenti MA; Bloch K; Daturi S; Mandelli V
    Diabetologia; 1973 Sep; ():311-6. PubMed ID: 4204091
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulinotropic action of a new sulfonylurea: gliclazide.
    Malaisse WJ; Leclercq-Meyer V
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):310-4. PubMed ID: 4626523
    [No Abstract]   [Full Text] [Related]  

  • 4. Unaltered glucagon secretion after seven days of sulphonylurea administration in normal subjects.
    Marco J; Valverde I
    Diabetologia; 1973 Sep; ():317-9. PubMed ID: 4204092
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on dose-response relationship of various sulfonylurea derivatives of the old and the new generation with further hints to extrapancreatic mechanisms of decreasing blood sugar].
    Haupt E; Köberich W; Cordes U; Beyer J; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2203. PubMed ID: 4198968
    [No Abstract]   [Full Text] [Related]  

  • 6. Special pharmacology of the new sulfonylurea glimepiride.
    Geisen K
    Arzneimittelforschung; 1988 Aug; 38(8):1120-30. PubMed ID: 2904269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
    Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
    Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of glimepiride and glibenclamide on insulin and glucagon secretion by the perfused rat pancreas.
    Ledercq-Meyer V; Akkan AG; Marchand J; Malaisse WJ
    Biochem Pharmacol; 1991 Sep; 42(8):1634-7. PubMed ID: 1930290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent findings in the use of 1st and 2nd generation hypoglycemic sulfonamides].
    Schöffling K; Haupt E; Köberich W; Beyer J
    Klin Wochenschr; 1973 Jan; 51(2):68-77. PubMed ID: 4631325
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 11. [Progress in therapy for diabetes mellitus--insulin-secretion inducing oral hypoglycemic agents].
    Nagashima K; Inagaki N
    Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):737-41. PubMed ID: 19472523
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of glycemia level on insulin secretion caused by an hypoglycemic sulfamide (glisoxepide) in dogs].
    Loubatières AL; Ribes G; Loubatières-Mariani MM
    C R Seances Soc Biol Fil; 1972; 166(8):1047-50. PubMed ID: 4573746
    [No Abstract]   [Full Text] [Related]  

  • 13. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
    Haupt E; Beyer J; Schöffling K
    Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in blood glucose and insulin in 4 normal subjects after administration of a single dose of glipizide and glibenclamide].
    Rizzi G; Isaia GC
    Minerva Med; 1974 Jan; 65(1):58-9. PubMed ID: 4214132
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepide. II. Repeated administration in combination with glucose.
    Haupt E; Köberich W; Beyer J; Schöffling K
    Diabetologia; 1971 Dec; 7(6):455-60. PubMed ID: 5004179
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanism of action of gliquidone (author's transl)].
    Zilker T; Ermler R; Henderkott U; Bottermann P
    Dtsch Med Wochenschr; 1975 Aug; 100(35):1733-4, 1739-41. PubMed ID: 808405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secretion of insulin under the influence of sulfonylurea derivates (SH)].
    Rothenbuchner G; Raptis S; Pfeiffer EF
    Wien Z Inn Med; 1973; 54(2):69-77. PubMed ID: 4203274
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmacology of S 1702, a new highly effective oral antibiabetic drug with unusual properties. 1. Pharmacological and hypoglycaemic activity, studies in different animal species.
    Duhault J; Boulanger M; Tisserand F; Bergi L
    Arzneimittelforschung; 1972 Oct; 22(10):1682-5. PubMed ID: 4677056
    [No Abstract]   [Full Text] [Related]  

  • 19. [Glipizide stimulation of insulin production in the pancreas of the anesthetized dog].
    Lefebvre P; Luyckx A
    Rev Med Liege; 1974 Mar; 29(5):137-9. PubMed ID: 4828058
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypoglycemia in hospitalized patients treated with sulfonylureas.
    Deusenberry CM; Coley KC; Korytkowski MT; Donihi AC
    Pharmacotherapy; 2012 Jul; 32(7):613-7. PubMed ID: 22570146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.